Cardiomatics

APRIL 5, 2024

Prolonged ambulatory ECG monitoring, commonly referred to as Holter testing, increases the chance of detecting abnormalities responsible for the symptoms of cardiovascular diseases, especially those whose pathognomonic symptoms occur only periodically. AFIB/AFL – atrial fibrillation or atrial flutter episodes.

Arrhythmia 92

Arrhythmia Tachycardia Bradycardia Electrocardiogram 92

DAIC

FEBRUARY 27, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. The acquisition of Laminar, Inc.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

DAIC

DECEMBER 19, 2023

OSA disproportionately affects the 92 million Americans living with cardiovascular disease (CVD), often goes undiagnosed (1) , and doubles the risk for heart failure and other serious cardiovascular conditions. FACC, FHRS, FHSC , Executive Medical Director, Texas Cardiac Arrhythmia Institute at St. David's Medical Center.

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

DAIC

FEBRUARY 7, 2024

This new document builds off of the previously published Best Practices for Consumer Cardiovascular Technology Solutions in January 2022. Cardiovascular disease is the leading cause of death globally, taking an estimated 695,000 lives in 2021 in the United States, about 1 in every 5 deaths, according to the CDC.

Technology 116

Technology Cardiovascular Disease Best Practices AFIB 116

DAIC

FEBRUARY 2, 2024

milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. million people died from cardiovascular diseases in 2019.

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

DAIC

JUNE 19, 2024

While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

DAIC

JULY 10, 2024

In a room of 20 people, it’s likely that about 10 of them, or half, will presently have some form of cardiovascular disease (CVD). CVD is among the most prevalent diseases in the U.S., Atrial fibrillation (AFib) cases have also surged, doubling from 28.3 and strokes and other CVDs are on the rise globally.

Technology 106

Technology Best Practices AFIB Patient Care 106